Biopharmaceutical Excipients Market Size, Share, Trends, Growth Outlook

Biopharmaceutical Excipients Market is estimated to increase at a growth rate of 6.3% CAGR over the forecast period from 2024 to 2030.

The Biopharmaceutical Excipients Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Solubilizes & Surfactants/Emulsifiers (Triglycerides, Esters, Others), Polyols (Mannitol, Sorbitol, Others), Carbohydrates (Sucrose, Dextrose, Starch, Others).

An Introduction to Biopharmaceutical Excipients Market in 2024

The Biopharmaceutical Excipients market in 2024 plays a critical role in drug formulation and delivery, providing essential ingredients that ensure stability, solubility, and bioavailability of biopharmaceutical products. Excipients, including fillers, binders, lubricants, and preservatives, are integral components of biologic formulations, enabling effective drug delivery systems and enhancing patient compliance. As the biopharmaceutical industry continues to grow rapidly, driven by the development of innovative biologic therapies, the demand for specialized excipients tailored to biologics' unique requirements escalates. Regulatory scrutiny, quality standards, and compatibility with biologic drugs drive excipient innovation and market dynamics, fostering collaborations between excipient manufacturers, biopharmaceutical companies, and regulatory agencies to ensure product safety and efficacy.

Biopharmaceutical Excipients Market Trend: Increasing Demand for Functional Excipients

A prominent trend in the Biopharmaceutical Excipients market is the rising demand for functional excipients that offer enhanced drug delivery, stability, and bioavailability. With the growing complexity of biopharmaceutical formulations, there is a need for excipients that can address specific formulation challenges and optimize the performance of biologic drugs. Excipients with functionalities such as controlled release, improved solubility, and enhanced stability are increasingly sought after by biopharmaceutical manufacturers to meet the evolving needs of drug development.

Biopharmaceutical Excipients Market Driver: Growth in Biologics Development and Manufacturing

The primary driver for the Biopharmaceutical Excipients market is the continuous growth in biologics development and manufacturing. Biologic drugs, including monoclonal antibodies, vaccines, and recombinant proteins, represent a significant and expanding segment of the pharmaceutical industry. As biologic drugs become more prevalent in the treatment of various diseases, there is a corresponding increase in the demand for excipients used in their formulation and manufacturing processes. Biopharmaceutical excipients play crucial roles in stabilizing biologic formulations, facilitating drug delivery, and ensuring product quality, driving market growth as biopharmaceutical companies seek high-quality excipients to support their manufacturing operations.

Biopharmaceutical Excipients Market Opportunity: Development of Specialized Excipients for Biologic Formulations

An opportunity in the Biopharmaceutical Excipients market lies in the development of specialized excipients tailored specifically for biologic formulations. As biologic drugs present unique formulation challenges compared to small molecule drugs, there is a growing need for excipients designed to address these challenges effectively. Opportunities exist for excipient manufacturers to innovate and create specialized excipients optimized for biologic drug delivery, stability in various formulations, compatibility with biologic molecules, and compatibility with advanced drug delivery technologies such as nanoparticles and liposomes. By developing excipients tailored to the specific requirements of biologic formulations, companies can differentiate themselves in the market and capture a larger share of the growing biopharmaceutical excipients segment.

Biopharmaceutical Excipients Market Segmentation

By Product
Solubilizes & Surfactants/Emulsifiers
-Triglycerides
-Esters
-Others
Polyols
-Mannitol
-Sorbitol
-Others
Carbohydrates
-Sucrose
-Dextrose
-Starch
-Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Biopharmaceutical Excipients Market Companies

Associated British Foods plc
BASF SE
Clariant
Colorcon
DFE Pharma
Evonik Industries AG
IMCD
J. RETTENMAIER & SÖHNE GmbH + Co KG
Merck KGaA
Roquette Frères
Sigachi Industries Ltd
Signet Excipients Pvt. Ltd (IMCD)
Spectrum Chemical Manufacturing Corp

 

 

Reasons to Buy the Biopharmaceutical Excipients Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Biopharmaceutical Excipients Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Biopharmaceutical Excipients Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Biopharmaceutical Excipients Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Biopharmaceutical Excipients Market Size Outlook, $ Million, 2021 to 2030
3.2 Biopharmaceutical Excipients Market Outlook by Type, $ Million, 2021 to 2030
3.3 Biopharmaceutical Excipients Market Outlook by Product, $ Million, 2021 to 2030
3.4 Biopharmaceutical Excipients Market Outlook by Application, $ Million, 2021 to 2030
3.5 Biopharmaceutical Excipients Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Biopharmaceutical Excipients Market Industry
4.2 Key Market Trends in Biopharmaceutical Excipients Market Industry
4.3 Potential Opportunities in Biopharmaceutical Excipients Market Industry
4.4 Key Challenges in Biopharmaceutical Excipients Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Biopharmaceutical Excipients Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Biopharmaceutical Excipients Market Outlook By Segments
7.1 Biopharmaceutical Excipients Market Outlook by Segments
By Product
Solubilizes & Surfactants/Emulsifiers
-Triglycerides
-Esters
-Others
Polyols
-Mannitol
-Sorbitol
-Others
Carbohydrates
-Sucrose
-Dextrose
-Starch
-Others

8 North America Biopharmaceutical Excipients Market Analysis And Outlook To 2030
8.1 Introduction to North America Biopharmaceutical Excipients Markets in 2024
8.2 North America Biopharmaceutical Excipients Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Biopharmaceutical Excipients Market size Outlook by Segments, 2021-2030
By Product
Solubilizes & Surfactants/Emulsifiers
-Triglycerides
-Esters
-Others
Polyols
-Mannitol
-Sorbitol
-Others
Carbohydrates
-Sucrose
-Dextrose
-Starch
-Others

9 Europe Biopharmaceutical Excipients Market Analysis And Outlook To 2030
9.1 Introduction to Europe Biopharmaceutical Excipients Markets in 2024
9.2 Europe Biopharmaceutical Excipients Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Biopharmaceutical Excipients Market Size Outlook By Segments, 2021-2030
By Product
Solubilizes & Surfactants/Emulsifiers
-Triglycerides
-Esters
-Others
Polyols
-Mannitol
-Sorbitol
-Others
Carbohydrates
-Sucrose
-Dextrose
-Starch
-Others

10 Asia Pacific Biopharmaceutical Excipients Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Biopharmaceutical Excipients Markets in 2024
10.2 Asia Pacific Biopharmaceutical Excipients Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Biopharmaceutical Excipients Market size Outlook by Segments, 2021-2030
By Product
Solubilizes & Surfactants/Emulsifiers
-Triglycerides
-Esters
-Others
Polyols
-Mannitol
-Sorbitol
-Others
Carbohydrates
-Sucrose
-Dextrose
-Starch
-Others

11 South America Biopharmaceutical Excipients Market Analysis And Outlook To 2030
11.1 Introduction to South America Biopharmaceutical Excipients Markets in 2024
11.2 South America Biopharmaceutical Excipients Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Biopharmaceutical Excipients Market size Outlook by Segments, 2021-2030
By Product
Solubilizes & Surfactants/Emulsifiers
-Triglycerides
-Esters
-Others
Polyols
-Mannitol
-Sorbitol
-Others
Carbohydrates
-Sucrose
-Dextrose
-Starch
-Others

12 Middle East And Africa Biopharmaceutical Excipients Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Biopharmaceutical Excipients Markets in 2024
12.2 Middle East and Africa Biopharmaceutical Excipients Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Biopharmaceutical Excipients Market size Outlook by Segments, 2021-2030
By Product
Solubilizes & Surfactants/Emulsifiers
-Triglycerides
-Esters
-Others
Polyols
-Mannitol
-Sorbitol
-Others
Carbohydrates
-Sucrose
-Dextrose
-Starch
-Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Associated British Foods plc
BASF SE
Clariant
Colorcon
DFE Pharma
Evonik Industries AG
IMCD
J. RETTENMAIER & SÖHNE GmbH + Co KG
Merck KGaA
Roquette Frères
Sigachi Industries Ltd
Signet Excipients Pvt. Ltd (IMCD)
Spectrum Chemical Manufacturing Corp

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Solubilizes & Surfactants/Emulsifiers
-Triglycerides
-Esters
-Others
Polyols
-Mannitol
-Sorbitol
-Others
Carbohydrates
-Sucrose
-Dextrose
-Starch
-Others